 20. Subjects requiring regular COX-2 inhibitor drugs or non-specific COX-1COX-2 inhibiting drugs, or high dose steroids except inhaled steroids or ocular steroids; subjects may be enrolled if willingable to undergo medication wash-out prior to the first dosing and to refrain from taking these drugs for the first 6 months of the study; 